Advanced search×

Optimising vancomycin doses in continuous infusion for septic patients

Int J Antimicrob Agents 37(4):1 (2011) PMID 21316927

DOI: 10.1016/j.ijantimicag.2010.12.009
Version: za2963e q8za4 q8zb9 q8zc2 q8zdc q8zef q8zfd q8zgd

Similar articles you may find interesting…

  1. Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapy.

    Int J Antimicrob Agents 37(6):531-5 (2011) PMID 21489756

    Data on the optimal amikacin regimen during continuous renal replacement therapy (CRRT) are scarce and the proposed loading dose of 10mg/kg may result in inadequate drug levels. The aim of this study was to describe the pharmacokinetics of a 25 mg/kg first dose of amikacin in septic shock patients tr...
  2. Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapy.

    Int J Antimicrob Agents 37(6):531-5 (2011) PMID 21489756

    Data on the optimal amikacin regimen during continuous renal replacement therapy (CRRT) are scarce and the proposed loading dose of 10mg/kg may result in inadequate drug levels. The aim of this study was to describe the pharmacokinetics of a 25 mg/kg first dose of amikacin in septic shock patients tr...
  3. Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic pati...

    Ther Drug Monit 32(6):749-56 (2010) PMID 20962708

    Because the sepsis-induced pharmacokinetic (PK) modifications need to be considered in aminoglycoside dosing, the present study aimed to develop a population PK model for amikacin (AMK) in severe sepsis and to subsequently propose an optimal sampling strategy suitable for Bayesian estimation of the...